First Time Loading...

CI Medical Co Ltd
TSE:3540

Watchlist Manager
CI Medical Co Ltd Logo
CI Medical Co Ltd
TSE:3540
Watchlist
Price: 4 065 JPY 1.37%
Updated: May 7, 2024
Section:
 

Relative Value

3540 price has not been updated for more than 6 years. This may indicate that the stock has been delisted.

The Relative Value of one CI Medical Co Ltd stock under the Base Case scenario is 5 612.6 JPY. Compared to the current market price of 4 065 JPY, CI Medical Co Ltd is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5 612.6 JPY
Undervaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
82
vs Industry
30
Median 3Y
1.2
Median 5Y
1.2
Industry
0.6
Forward
0.8
More Details
19.5
P/E
P/E
Price to Earnings
19.5
vs History
42
vs Industry
25
Median 3Y
19.1
Median 5Y
19.4
Industry
16.4
Forward
16.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
6
Median 3Y
24.7
Median 5Y
24.7
Industry
8
More Details
39.9
P/FCFE
P/FCFE
Price to FCFE
39.9
vs History
26
vs Industry
12
Median 3Y
-9.2
Median 5Y
16.9
Industry
15.7
More Details
2
P/B
P/B
Price to Book Value
2
vs History
92
vs Industry
33
Median 3Y
2.7
Median 5Y
2.8
Industry
1.6
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
47
vs Industry
26
Median 3Y
1.2
Median 5Y
1.2
Industry
0.7
Forward
1.1
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
38
vs Industry
21
Median 3Y
4.6
Median 5Y
4.4
Industry
2.2
More Details
13.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.8
vs History
19
vs Industry
18
Median 3Y
12.2
Median 5Y
12.1
Industry
8.4
Forward
11.2
More Details
18.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.6
vs History
11
vs Industry
19
Median 3Y
13.6
Median 5Y
13.3
Industry
12.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
5
Median 3Y
24.6
Median 5Y
24.3
Industry
9.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-7
Median 5Y
12.7
Industry
12.6
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
87
vs Industry
30
Median 3Y
2.2
Median 5Y
2.5
Industry
1.1
More Details

Multiples Across Competitors

Competitors Multiples
CI Medical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
CI Medical Co Ltd
TSE:3540
40.6B JPY 0.9 19.5 13.8 18.6
US
Amazon.com Inc
NASDAQ:AMZN
2T USD 3.3 52.1 20.2 41.2
ZA
Naspers Ltd
JSE:NPN
768B Zac 0 0 0 0
UK
in Style Group PLC
LSE:ITS
201.8B GBP 3 731.5 -37 596.5 -50 530.6 -36 808.2
CN
Alibaba Group Holding Ltd
NYSE:BABA
203.9B USD 1.6 14.7 8 8
CN
Pinduoduo Inc
NASDAQ:PDD
184.2B USD 5.4 22.1 18.8 19
NL
Prosus NV
AEX:PRX
85B EUR 17.6 8.4 -234.9 -234.9
CN
Meituan
HKEX:3690
652.5B HKD 2.2 43.4 48.5 48.5
AR
Mercadolibre Inc
NASDAQ:MELI
83.5B USD 5.3 73.9 31.6 40.5
UY
MercadoLibre Inc
BMV:MELIN
1.4T MXN 5.2 73.1 31.3 40.1
US
DoorDash Inc
NYSE:DASH
48B USD 5.3 -114.4 738.1 -92.9
P/E Multiple
Earnings Growth
JP
CI Medical Co Ltd
TSE:3540
Average P/E: 38.4
19.5
75%
US
Amazon.com Inc
NASDAQ:AMZN
52.1
136%
ZA
N
Naspers Ltd
JSE:NPN
Not Available
-11%
UK
i
in Style Group PLC
LSE:ITS
Negative Multiple: -37 596.5 N/A
CN
Alibaba Group Holding Ltd
NYSE:BABA
14.7
144%
CN
Pinduoduo Inc
NASDAQ:PDD
22.1
141%
NL
Prosus NV
AEX:PRX
8.4
-13%
CN
Meituan
HKEX:3690
43.4
288%
AR
Mercadolibre Inc
NASDAQ:MELI
73.9
221%
UY
MercadoLibre Inc
BMV:MELIN
73.1
221%
US
DoorDash Inc
NYSE:DASH
Negative Multiple: -114.4 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
CI Medical Co Ltd
TSE:3540
Average EV/EBITDA: 113.8
13.8
68%
US
Amazon.com Inc
NASDAQ:AMZN
20.2
116%
ZA
N
Naspers Ltd
JSE:NPN
Not Available N/A
UK
i
in Style Group PLC
LSE:ITS
Negative Multiple: -50 530.6 N/A
CN
Alibaba Group Holding Ltd
NYSE:BABA
8
44%
CN
Pinduoduo Inc
NASDAQ:PDD
18.8
199%
NL
Prosus NV
AEX:PRX
Negative Multiple: -234.9 N/A
CN
Meituan
HKEX:3690
48.5
606%
AR
Mercadolibre Inc
NASDAQ:MELI
31.6
127%
UY
MercadoLibre Inc
BMV:MELIN
31.3
127%
US
DoorDash Inc
NYSE:DASH
738.1
N/A
EV/EBIT Multiple
EBIT Growth
JP
CI Medical Co Ltd
TSE:3540
Average EV/EBIT: 30.8
18.6
N/A
US
Amazon.com Inc
NASDAQ:AMZN
41.2
155%
ZA
N
Naspers Ltd
JSE:NPN
Not Available N/A
UK
i
in Style Group PLC
LSE:ITS
Negative Multiple: -36 808.2 N/A
CN
Alibaba Group Holding Ltd
NYSE:BABA
8
68%
CN
Pinduoduo Inc
NASDAQ:PDD
19
205%
NL
Prosus NV
AEX:PRX
Negative Multiple: -234.9 N/A
CN
Meituan
HKEX:3690
48.5
472%
AR
Mercadolibre Inc
NASDAQ:MELI
40.5
158%
UY
MercadoLibre Inc
BMV:MELIN
40.1
158%
US
DoorDash Inc
NYSE:DASH
Negative Multiple: -92.9 N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.